Related Experiment Video
Updated: Dec 16, 2025

Two Techniques to Create Hypoparathyroid Mice: Parathyroidectomy Using GFP Glands and Diphtheria-Toxin-Mediated Parathyroid Ablation
Published on: March 14, 2017
Reduced Calcium Sensing Receptor (CaSR) Expression Is Epigenetically Deregulated in Parathyroid Adenomas
Priyanka Singh1, Sanjay Kumar Bhadada1, Divya Dahiya2
1Department of Endocrinology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Aim:
Reduced calcium sensing receptor (CaSR) expression has been implicated in parathyroid tumorigenesis, but the underlying mechanism remains elusive. Accordingly, we aimed to explore the epigenetic changes (DNA methylation and histone modifications) involved in CaSR regulation in sporadic parathyroid adenomas and correlate epigenetic state with disease indices.
Experimental Design:
Forty sporadic parathyroid adenomas and 10 control parathyroid tissues were studied. Real-time quantitative PCR (qPCR) for mRNA and immunohistochemistry for protein expression of CaSR were performed. The methylation status of the CaSR promoter 2 was determined by bisulphite sequencing analysis of sodium bisulphite-converted DNA. To determine the role of histone modifications in the CaSR regulation, chromatin immunoprecipitation-qPCR assay was performed.
Results:
Real-time qPCR revealed reduced CaSR mRNA expression with a fold reduction of 0.12 (P < 0.0001) in parathyroid adenomas. Immunohistochemistry revealed reduced protein expression of CaSR in 90% (36/40) of adenomas. The promoter 2 region of CaSR displayed significant hypermethylation in 45% (18/40) of the adenomas compared with the controls (6.7%; 1 of 10) (P < 0.002). Bisulphite sequencing analysis revealed maximum methylated CpG at glial cell missing 2 binding site on the CaSR promoter 2 compared to other CpG sites. The methylation status of CaSR correlated directly with plasma intact parathyroid hormone levels in patients with parathyroid adenoma. With chromatin immunoprecipitation-qPCR analysis, H3K9me3 levels showed increased enrichment by 10-fold in adenomas and correlated with CaSR-mRNA expression (r = 0.61; P < 0.003). Treatment with 5-aza-2'deoxycytidine restored the expression of CaSR in a parathyroid cell line.
Conclusion:
Our data suggest that hypermethylation and increased H3K9me3 of the CaSR promoter 2 are involved in silencing CaSR expression in sporadic parathyroid adenoma.
Insights
Epigenetic changes, including DNA hypermethylation and H3K9me3 modifications, silence calcium sensing receptor (CaSR) expression in parathyroid adenomas, contributing to parathyroid tumorigenesis.
Area of Science:
- Endocrinology
- Molecular Biology
- Epigenetics
Background:
- Reduced calcium sensing receptor (CaSR) expression is linked to parathyroid tumor development.
- The precise epigenetic mechanisms driving CaSR dysregulation in parathyroid adenomas are not fully understood.
Purpose of the Study:
- To investigate epigenetic alterations, specifically DNA methylation and histone modifications, affecting CaSR expression in sporadic parathyroid adenomas.
- To correlate these epigenetic changes with clinical indicators of parathyroid disease.
Main Methods:
- Analysis of CaSR mRNA and protein levels in 40 parathyroid adenomas and 10 controls using qPCR and immunohistochemistry.
- Bisulphite sequencing to assess CaSR promoter 2 methylation.
- Chromatin immunoprecipitation followed by qPCR (ChIP-qPCR) to evaluate histone modifications (H3K9me3).
- In vitro studies using 5-aza-2'deoxycytidine to assess CaSR expression restoration.
Main Results:
- Parathyroid adenomas exhibited significantly reduced CaSR mRNA (0.12-fold) and protein expression (in 90% of cases).
- CaSR promoter 2 showed significant hypermethylation in 45% of adenomas compared to controls (6.7%), with maximum methylation at a GCM2 binding site.
- Increased H3K9me3 enrichment (10-fold) was observed in adenomas, correlating with reduced CaSR mRNA.
- CaSR promoter methylation correlated directly with plasma intact parathyroid hormone levels.
- 5-aza-2'deoxycytidine treatment restored CaSR expression in a parathyroid cell line.
Conclusions:
- Hypermethylation and increased H3K9me3 of the CaSR promoter 2 are key mechanisms contributing to CaSR silencing in sporadic parathyroid adenomas.
- These epigenetic modifications play a significant role in parathyroid tumorigenesis.
More Related Videos
03:57Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
Published on: July 14, 2023
13:40Live Cell Calcium Imaging Combined with siRNA Mediated Gene Silencing Identifies Ca2+ Leak Channels in the ER Membrane and their Regulatory Mechanisms
Published on: July 7, 2011
Related Concept Videos
The Parathyroid Glands
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
Calmodulin-dependent Signaling
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
Skeleton and Calcium Homeostasis
Synthesis and Functions of Calcitonin
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
GPCRs Regulate Adenylyl Cylase Activity
GPCR Desensitization